StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$920.69−2.65 (-0.29%)

Close on Nov 20, 2026Market cap $95.24BP/E 20.3Yield –

Regeneron Pharmaceuticals Other Revenue by Quarter

Other Revenue (Royalties, BARDA Funding & Contract Manufacturing) ($M) ($M)

Regeneron Pharmaceuticals Other Revenue: $310M in Q3 2026, up 56.4% from a year earlier. That is the highest of the 27 quarters on record here.

Latest, Q3 2026
310
Period ended Sep 30, 2026
Change on a year earlier
+56.4%
198 in Q3 2025
History
27 quarters
Since Q1 2020
Sources
22
Documents cited below

Where the Q3 2026 figure comes from

Source: Form 10-Q (filed 2026-10-30) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Operations.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Revenue (Royalties, BARDA Funding & Contract Manufacturing) ($M) ($M)Year on yearSource
Q3 2026Sep 30, 2026310+56.4%Form 10-Q (filed 2026-10-30) ↗
Q2 2026Jun 30, 2026193+5.1%Form 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 2026171+109.0%Form 10-Q (filed 2026-04-29) ↗
Q4 2025Dec 31, 2025239+33.0%Form 10-K (filed 2026-02-04) ↗
Q3 2025Sep 30, 2025198+73.6%Form 10-Q (filed 2026-10-30) ↗
Q2 2025Jun 30, 2025184+76.0%Form 10-Q (filed 2026-07-30) ↗
Q1 2025Mar 31, 202581.9-29.9%Form 10-Q (filed 2026-04-29) ↗
Q4 2024Dec 31, 2024179-15.6%Form 10-K (filed 2026-02-04) ↗
Q3 2024Sep 30, 2024114-17.4%Form 10-Q (filed 2025-10-28) ↗
Q2 2024Jun 30, 2024105+50.8%Form 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 2024117+0.8%Form 10-Q (filed 2025-04-29) ↗
Q4 2023Dec 31, 2023213+66.4%Form 10-K (filed 2026-02-04) ↗
Q3 2023Sep 30, 2023138+64.3%Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 202369.3+17.1%Form 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 2023116+23.4%Form 10-Q (filed 2024-05-02) ↗
Q4 2022Dec 31, 2022128+48.1%Form 10-K (filed 2025-02-05) ↗

Breakdown

What makes up other Revenue

Cite this data

StockData. (2026). Regeneron Pharmaceuticals Other Revenue ($M), quarterly Q1 2020–Q3 2026 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/rev-other-total

See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?